Literature DB >> 14522952

STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene.

Lorena Lerner1, Melissa A Henriksen, Xiaokui Zhang, James E Darnell.   

Abstract

We describe a detailed time course of the assembly and disassembly of a STAT3-dependent, glucocorticoid-supplemented enhanceosome for the alpha2-macroglobulin (alpha2-M) gene and compare this with a detailed time course of transcription of the gene by run-on analysis. The glucocorticoid receptor (GR) can associate with the enhanceosome without STAT3. Furthermore, the enhanceosome contains c-Jun/c-Fos and OCT-1 constitutively. All of these factors (GR, c-Jun, OCT-1) have transcription activation domains, but STAT3 is required for the observed transcriptional increase. The time course of enhanceosome occupation by GR and tyrosine-phosphorylated STAT3 shows that these transcription factors precede by approximately 5-10 min the arrival of RNA polymerase II (Pol II). The enhanceosome remains assembled for approximately 90 min in the continued presence of both inducers. When IL-6 and Dex are removed (after 30 min of treatment), the disappearance within an additional 30 min of the established enhanceosome indicates that renewal of STAT3 and GR binding must occur in the continued presence of IL-6+Dex. Compared with the total nuclear tyrosine-phosphorylated STAT3 capable of binding DNA, the chromatin-associated STAT3 resists dephosphorylation and appears to recycle to maintain the enhanceosome. Run-on transcription shows a lag after full enhanceosome occupation that can be largely but not completely explained by the approximately 30 min transit time of Pol II across the alpha2-Mlocus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522952      PMCID: PMC218150          DOI: 10.1101/gad.1135003

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  47 in total

Review 1.  An extensive network of coupling among gene expression machines.

Authors:  Tom Maniatis; Robin Reed
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 2.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

3.  Distinct transcriptional activation functions of STAT1alpha and STAT1beta on DNA and chromatin templates.

Authors:  Natalia Zakharova; Elena S Lymar; Edward Yang; Sohail Malik; J Jillian Zhang; Robert G Roeder; James E Darnell
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

4.  Modifying gene expression programs by altering core promoter chromatin architecture.

Authors:  Stavros Lomvardas; Dimitris Thanos
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

5.  Deciphering the transcriptional histone acetylation code for a human gene.

Authors:  Theodora Agalioti; Guoying Chen; Dimitris Thanos
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

6.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  RNA polymerase II accumulation in the promoter-proximal region of the dihydrofolate reductase and gamma-actin genes.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  Renin inhibition by synthetic phosphatidyl and phosphorylethanolamines.

Authors:  M Miyazaki; K Hosoki; K Yamamoto
Journal:  Jpn Circ J       Date:  1976-08

9.  5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.

Authors:  P B Sehgal; E Derman; G R Molloy; I Tamm; J E Darnell
Journal:  Science       Date:  1976-10-22       Impact factor: 47.728

10.  Role of metazoan mediator proteins in interferon-responsive transcription.

Authors:  Joe F Lau; Inna Nusinzon; Darya Burakov; Leonard P Freedman; Curt M Horvath
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  38 in total

1.  Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.

Authors:  Marylynn Snyder; Xin-Yun Huang; J Jillian Zhang
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Tissue-specific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids.

Authors:  Thomas P J Hofer; Marion Frankenberger; Jörg Mages; Roland Lang; Peter Meyer; Reinhard Hoffmann; Alain Colige; Löms Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2007-12-14       Impact factor: 4.599

Review 3.  Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.

Authors:  Jamie R Flammer; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2011-04-21

4.  Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Authors:  Tiancen Hu; Jennifer E Yeh; Luca Pinello; Jaison Jacob; Srinivas Chakravarthy; Guo-Cheng Yuan; Rajiv Chopra; David A Frank
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

5.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

6.  The type I interferon signaling pathway is a target for glucocorticoid inhibition.

Authors:  Jamie R Flammer; Jana Dobrovolna; Megan A Kennedy; Yurii Chinenov; Christopher K Glass; Lionel B Ivashkiv; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

7.  Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells.

Authors:  Marylynn Snyder; Xin-Yun Huang; J Jillian Zhang
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 8.  Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2006-10-27       Impact factor: 7.217

9.  MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer.

Authors:  Suresh B Pakala; Suresh K Rayala; Rui-An Wang; Kazufumi Ohshiro; Prakriti Mudvari; Sirigiri Divijendra Natha Reddy; Yi Zheng; Ricardo Pires; Sandra Casimiro; M Radhakrishna Pillai; Luis Costa; Rakesh Kumar
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

10.  Prediction and experimental validation of novel STAT3 target genes in human cancer cells.

Authors:  Young Min Oh; Jong Kyoung Kim; Yongwook Choi; Seungjin Choi; Joo-Yeon Yoo
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.